CD4 and lung cancer: The high frequency of CD4+ T cells in TILs and malignant pleural effusions (MPEs) correlates with a favorable prognosis in lung cancer patients [8, 9]; however, other studies indicate that the high number of CD8+ T cells, not CD4+ T cells, in TILs has a good clinical outcome [10–12].